Memphasys receives early Thai FDA Felix approval
Memphasys' Felix System has received earlier than anticipated approval from the Thai Food and Drug Administration.
Market Cap $126.0M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| SND | Corporate Governance Statement | 17/04/18 | ||
| SND | Appendix 3B | 08/03/18 | ||
| SND | Appendix 3B | 08/03/18 | ||
| SND | Change of Director's Interest | 08/03/18 | ||
| SND | Change in substantial holding | 27/02/18 | ||
| SND Corporate Governance Statement | |||
| 17/04/18 | |||
| SND Appendix 3B | |||
| 08/03/18 | |||
| SND Appendix 3B | |||
| 08/03/18 | |||
| SND Change of Director's Interest | |||
| 08/03/18 | |||
| SND Change in substantial holding | |||
| 27/02/18 | |||